Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up 249%.
Quick way to Jinx Things...
Stormin..Live Quote
We're still not...
Plansource Invites DarioHealth (DRIO) Into 50 Broker Partnership Network, Serving 5 Million Patients.
This looks like a coup for DarioHealth (DRIO), getting it's digital health solutions in front of more than 5 million new potential...
Ardelyx (ARDX) $3.40, Receives FDA Approval.
BooYah, Ardelyx shoots and we score (again) last week..but wait, there's more!
It trades down post-approval as short-term...
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...
And We Have a $26.4 Billion Winning Trifecta!
THREE PREVIOUS WINNERS*
Immunomedics (IMMU) $3 to $87 up 2,800%, a gain of $20.7 billion. Acquired...
And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%.
LIVE QUOTE
Longer Term Chart
Ardelyx Enters the Danger Zone* With Tenapanor.
Adding Pressure BioSciences (PBIO) $0.80 to Watch List.
Long Time Coming, Pressure Bio Reaches Turning Point. Science Finally Meets Revenues.
Photo Ric Schumacher CEO
Sanofi (SNY) to Acquire Provention Bio (PRVB) for $25 a Share. Gains 243%.
Up 416%, from Adding it to 2022 Watch List!
Great way to wake up after a night of hard...
The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s Novel Topical Ketamine Delivery.
Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side Effects
Ardelyx (ARDX) Firmly Above Resistance.
Were not traders and we don't do technical analysis, but we could see this coming from a mile away. Next stop $9.00...